Post Resch Tallon Group »

Syndax Pharmaceuticals shares owned by Post Resch Tallon Group

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Post Resch Tallon Group from 13F filings

Historical chart of Post Resch Tallon Group investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Post Resch Tallon Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Post Resch Tallon Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $397k 26k 15.39

More positions owned by Post Resch Tallon Group

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 3000 Etf (IWV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadstone Net Lease (BNL)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p Scp Etf (IJR)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Exelixis (EXEL)
Spdr Series Trust Portfolio S&p400 (SPMD)
Ark Etf Tr Innovation Etf (ARKK)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Rus Md Cp Gr Etf (IWP)
Metropcs Communications (TMUS)
Ishares Tr Rus Tp200 Gr Etf (IWY)

View all positions for Post Resch Tallon Group

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Goldman Sachs Group
Vanguard Group
Point72 Asset Management
State Street Corporation
Eversept Partners
Adage Capital Partners GP
Kingdon Capital Management
Franklin Resources
Geode Capital Management
Soleus Capital Management
Assenagon Asset Management
UBS Group
Qube Research & Technologies

View all funds holding Syndax Pharmaceuticals